Do More With Reuters
Partner Services

Quote For Genmab A/S

Genmab A/S (GEN.CO) (Copenhagen Stock Exchange)
sector: Healthcare · industry: Biotechnology ·
As of  25 Nov 2009
73.75DKK
Price Change
-6.00
Percent Change
-7.52%
 
Research a stock:   symbol lookup
kr.73.75
25 Nov 2009
-7.52%
kr.79.75
kr.79.75
979,056
kr.79.75
kr.72.50
kr.278.00
kr.79.00
0.61
728,444

 

News

Key Developments

Officers

Name Current Position Compensation
Widmer, Michael Chairman of the Board --
Drakeman, Lisa President, Chief Executive Officer, Director --
Gersel Pedersen, Anders Deputy Chairman of the Board --

Key Ratios and Statistics

Share Related Items
Market Cap (Mil.) kr.3,581.34
Shares Outstanding (Mil.) 44.91
Float (Mil.) 39.80
Dividend Information
Yield % --
Annual Dividend (kr. DKK) 0.00
Payout Ratio(TTM) % --
Financial Strength
Quick Ratio 1.82
Current Ratio 1.82
LT Debt/Equity 1.06
Total Debt/Equity 1.45
Valuation Ratios
Price/Earnings(TTM) --
Price/Sales(TTM) 6.99
Price/Book(TTM) 1.93
Price/Cash Flow(TTM) --
Per Share Data
Earnings(TTM) kr.-18.76
Sales(TTM) kr.11.42
Book Value(MRQ) kr.41.29
Cash Flow(TTM) kr.-16.49
Cash(MRQ) kr.30.74
Management Effectiveness
Return on Equity(TTM) -38.25
Return on Assets(TTM) -26.51
Return on Investment(TTM) -38.00
Margins
Gross Margin(TTM) % 91.75
Operating Margin(TTM) % -175.24
Profit Margin(TTM) % -164.22

Commodities

Commodity Last Pct Chg Trade Date/Time
Oil 78.08 -0.46% 11/26 10:07 IST
Gold 1194.5 +0.63% 11/26 09:49 IST